Skip to main content

Advertisement

SpringerLink
Log in

MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Aucouturier J, Dupuis L, Ganne V (2001) Adjuvants designed for veterinary and human vaccines. Vaccine 19:2666

    Article  PubMed  CAS  Google Scholar 

  2. Boon T, Old LJ (1997) Cancer tumor antigens. Curr Opin Immunol 9:681

    Article  PubMed  CAS  Google Scholar 

  3. Cheville JC, Roche PC (1999) MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors. Mod Pathol 12:974

    PubMed  CAS  Google Scholar 

  4. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40:360

    Article  PubMed  CAS  Google Scholar 

  5. Flynn GC, Pohl J, Flocco MT, Rothman JE (1991) Peptide-binding specificity of the molecular chaperone BiP. Nature 353:726

    Article  PubMed  CAS  Google Scholar 

  6. Kawakami S, Yamashita F, Hashida M (2000) Disposition characteristics of emulsions and incorporated drugs after systemic or local injection. Adv Drug Deliv Rev 45:77

    Article  PubMed  CAS  Google Scholar 

  7. Ma JH, Sui YF, Ye J, Ya-Yu Huang, Zeng-Shan Li, Guang-Sheng Chen, Ping Qu, Hong-Ping Song, Xiu-Min Zhang (2005) Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo. Cancer Immunol Immunother 54:907

    Article  PubMed  CAS  Google Scholar 

  8. Manmohan Singh, Derek O’Hagan (1999) Advances in vaccine adjuvants. Nat Biotechnol 17:1075

    Article  PubMed  CAS  Google Scholar 

  9. Melief CJ, Kast WM (1995) T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol Rev 145:167

    Article  PubMed  CAS  Google Scholar 

  10. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target specific nanoparticles: theory to practice. Pharmacol Rev 53:283

    PubMed  CAS  Google Scholar 

  11. Myc A, Kukowska-Latallo JF, Bielinska AU, Cao P, Myc PP, Janczak K, Sturm TR, Grabinski MS, Landers JJ, Young KS, Chang J, Hamouda T, Olszewski MA, Baker JR Jr (2003) Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemlsion. Vaccine 21:3801

    Article  PubMed  CAS  Google Scholar 

  12. Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647

    Article  PubMed  CAS  Google Scholar 

  13. Pan G, Shawer M, Oie S, Lu DR (2003) In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system. Pharm Res 20:738

    Article  PubMed  CAS  Google Scholar 

  14. Serguei V, Vinogradov, Tatiana K, Bronich, Alexander V Kabanov (2002) Nanosized cationic hydrogels for drug delivery: preparation, properties, and interactions with cells. Adv Drug Deliv Rev 54:135

  15. Shen Z, Reznikoff G, Dranoff G, Rock KL (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158:2723

    PubMed  CAS  Google Scholar 

  16. Sudo T, Kuramoto T, Komiya S, Inoue A, Itoh K (1997) Expression of MAGE genes in osteosarcoma. J Orthop Res 15:128

    Article  PubMed  CAS  Google Scholar 

  17. Sun YJ, Wu DC, Cao YX, Sui YF (2005) Preparation and characterization of nanoemulsion. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 21:69

    PubMed  CAS  Google Scholar 

  18. Suzue K, Young RA (1996) Adjuvant-free Mycobacterium tuberculosis hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 156:873

    PubMed  CAS  Google Scholar 

  19. Suzue K, Zhou X, Eisen HN, Young RA (1997) Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA 94:13146

    Article  PubMed  CAS  Google Scholar 

  20. Van den Eynde BJ, van der Bruggen P (1997) T cell defined tumor antigens. Curr Opin Immunol 9:684

    Article  PubMed  CAS  Google Scholar 

  21. Wu H, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, Rossler BJ (2001) Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm 221:23

    Article  PubMed  CAS  Google Scholar 

  22. Ye J, Chen GS, Song HP, Li ZS, Huang YY, Qu P, Sun YJ, Zhang XM, Sui YF (2004) Heat shock protein 70/MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo. Cancer Immunol Immunother 53:825

    Article  PubMed  CAS  Google Scholar 

  23. Zhu X, Zhao X, Burkholder WF, Gragerov A, Ogata CM, Gottesman ME, Hendrickson WA (1996) Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272:1606

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the China National Natural Science Foundation (No. 30271464).

Author information

Authors and Affiliations

  1. State Key Laboratory of Cancer Biology, Department of Pathology, Xi Jing Hospital, Fourth Military Medical University, Xi’an, 710032, Shaanxi Province, China

    Wei Ge, Yan-Fang Sui, Yu-Jing Sun, Guang-Sheng Chen, Zeng-Shan Li, Shao-Yan Si, Pei-Zhen Hu, Yang Huang & Xiu-Min Zhang

  2. Department of Chemistry, Fourth Military Medical University Xi’an, 710032, Shaanxi Province, China

    Dao-Cheng Wu

Authors
  1. Wei Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan-Fang Sui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dao-Cheng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu-Jing Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guang-Sheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zeng-Shan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shao-Yan Si
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pei-Zhen Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yang Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiu-Min Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan-Fang Sui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ge, W., Sui, YF., Wu, DC. et al. MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo. Cancer Immunol Immunother 55, 841–849 (2006). https://doi.org/10.1007/s00262-005-0073-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-005-0073-y

Keywords

Search

Navigation